Korsana Biosciences Inc

NAS:KRSAHealth Technologynasdaq_composite

$31.41−3.00%At closeAt close · Tue 20 Oct · ≈ AED 115.35 · Market cap $1.43B · Next earnings Tue 10 Nov

USD millions	FY2021	FY2021	FY2022	FY2023	FY2025	FY2025	YoY
Cash & cash equivalents	54.4	54.0	13.4	7.6	3.2	3.2	+0.2%
Cash & short-term investments	54.4	54.0	13.4	7.6	3.2	3.2	+0.2%
Receivables	0.0	0.1	0.1	0.0	0.6	1.0	+79.9%
Total current assets	58.5	55.5	14.8	8.0	4.2	4.6	+9.7%
Property, plant & equipment	6.9	0.1	0.0	0.0	0.0	0.0	—
Total assets	115.4	59.3	18.1	13.4	9.6	10.0	+4.3%
Payables	1.1	1.8	3.0	1.2	0.4	0.5	+30.3%
Total current liabilities	17.0	11.1	7.6	2.1	0.7	0.9	+24.1%
Total debt	—	—	—	0.0	0.0	0.0	—
Net debt	—	—	—	(7.6)	(3.2)	(3.2)	−0.2%
Total equity	59.5	48.2	10.5	11.3	8.9	9.1	+2.7%
Retained earnings	(163.4)	(215.1)	(259.2)	(264.4)	(267.5)	(271.0)	−1.3%

USD millionsUpdated Tue 4 Aug ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.